A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemia (Q83015673)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 March 2006
edit
Language Label Description Also known as
English
A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemia
scientific article published on 29 March 2006

    Statements

    title
    A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemia (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    16574225
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574225%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    18 January 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q83015673&oldid=1829483523"